Cargando…
Iloprost for COVID-19-related vasculopathy
Autores principales: | Moezinia, Carine J, Ji-Xu, Antonio, Azari, Arianna, Horlick, Serena, Denton, Christopher, Stratton, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351406/ https://www.ncbi.nlm.nih.gov/pubmed/32838311 http://dx.doi.org/10.1016/S2665-9913(20)30232-0 |
Ejemplares similares
-
Iloprost in COVID-19: The Rationale of Therapeutic Benefit
por: Faggioli, Paola Maria, et al.
Publicado: (2021) -
Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study
por: Gordon, Jessica K, et al.
Publicado: (2022) -
COVID-19-related vasculopathy of the brain
por: Liang, Hui Wen, et al.
Publicado: (2021) -
Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Magnan, Marie-Anne, et al.
Publicado: (2021) -
Single-Breath Counting Test to Start Non-Invasive Respiratory Support in COVID-19 Patients: Early Detection and the Eternal Dilemma. Comment on Longhitano et al. Single-Breath Counting Test Predicts Non-Invasive Respiratory Support Requirements in Patients with COVID-19 Pneumonia. J. Clin. Med. 2022, 11, 179
por: Oldani, Stefano, et al.
Publicado: (2022)